A subset of human 35S U5 proteins, including Prp19, function prior to catalytic step 1 of splicing

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Olga V. Makarova - , Max Planck Institute for Biophysical Chemistry (Karl Friedrich Bonhoeffer Institute) (Autor:in)
  • Evgeny M. Makarov - , Max Planck Institute for Biophysical Chemistry (Karl Friedrich Bonhoeffer Institute) (Autor:in)
  • Henning Urlaub - , Max Planck Institute for Biophysical Chemistry (Karl Friedrich Bonhoeffer Institute) (Autor:in)
  • Cindy L. Will - , Max Planck Institute for Biophysical Chemistry (Karl Friedrich Bonhoeffer Institute) (Autor:in)
  • Marc Gentzel - , European Molecular Biology Laboratory (EMBL) Heidelberg (Autor:in)
  • Matthias Wilm - , European Molecular Biology Laboratory (EMBL) Heidelberg (Autor:in)
  • Reinhard Lührmann - , Max Planck Institute for Biophysical Chemistry (Karl Friedrich Bonhoeffer Institute) (Autor:in)

Abstract

During catalytic activation of the spliceosome, snRNP remodeling events occur, leading to the formation of a 35S U5 snRNP that contains a large group of proteins, including Prp19 and CDC5, not found in 20S U5 snRNPs. To investigate the function of 35S U5 proteins, we immunoaffinity purified human spliceosomes that had not yet undergone catalytic activation (designated BΔU1), which contained U2, U4, U5, and U6, but lacked U1 snRNA. Comparison of the protein compositions of BΔU1 and activated B* spliceosomes revealed that, whereas U4/U6 snRNP proteins are stably associated with BΔU1 spliceosomes, 35S U5-associated proteins (which are present in B*) are largely absent, suggesting that they are dispensable for complex B formation. Indeed, immunodepletion/complementation experiments demonstrated that a subset of 35S U5 proteins including Prp19, which form a stable heteromeric complex, are required prior to catalytic step 1 of splicing, but not for stable integration of U4/U6.U5 tri-snRNPs. Thus, comparison of the proteomes of spliceosomal complexes at defined stages can provide information as to which proteins function as a group at a particular step of splicing.

Details

OriginalspracheEnglisch
Seiten (von - bis)2381-2391
Seitenumfang11
FachzeitschriftEMBO Journal
Jahrgang23
Ausgabenummer12
PublikationsstatusVeröffentlicht - 16 Juni 2004
Peer-Review-StatusJa
Extern publiziertJa

Externe IDs

PubMed 15175653
ORCID /0000-0002-4482-6010/work/142251042

Schlagworte

Schlagwörter

  • Mass spectrometry, Proteomics, Prp19/CDC5 35S U5 snRNP, Spliceosome